CSRXP WELCOMES FDA APPROVAL OF FIRST INTERCHANGEABLE BIOLOGIC FOR INSULIN
Jul 29, 2021
Interchangeable Products Will Help Increase Prescription Drug Competition and… Read More
© 2024 CSRXP- All Rights Reserved
Press Release
CSRXP: SENATE JUDICIARY COMMITTEE CRACKS DOWN ON BIG PHARMA PATENT ABUSE
Jul 29, 2021
Unanimous, Bipartisan Passage of Bills Targeting Brand Name Drug Companies’… Read More
CSRXP: OVERSIGHT REPORT ADDS TO MOMENTUM IN WASHINGTON TO HOLD BIG PHARMA ACCOUNTABLE
Jul 8, 2021
U.S. House Oversight & Reform Committee Report Shines Light on Branded… Read More
CSRxP: Big Pharma Flaunts Disregard for Rx Affordability With Third Major Round of Pandemic Price Hikes
Jul 1, 2021
Pharmaceutical Companies Increase Prices on 32 Brand Name Drugs to Start July… Read More
ICYMI: BIG PHARMA USES INFLUENCE OVER PATIENT GROUPS & ASTROTURF TACTICS TO UNDERMINE RX SOLUTIONS
Jun 30, 2021
New Report Reveals “Hidden Hand” Of Brand Name Drug Industry In case you… Read More
CSRXP APPLAUDS U.S. HOUSE PROBE INTO BIOGEN PRICING OF ADUHELM
Jun 25, 2021
Pallone and Maloney Announce Joint Investigation into Massive Price Tag on… Read More
CSRXP: WYDEN RX PRICING PRINCIPLES ADD TO MOMENTUM IN WASHINGTON TO HOLD BIG PHARMA ACCOUNTABLE
Jun 22, 2021
Lawmakers Must Advance Solutions to Lower Drug Prices Washington,… Read More
CSRXP: FDA APPROVAL AND SUBSEQUENT BIOGEN PRICING OF ADUCANUMAB DEMAND RETROSPECTION, REFORM
Jun 11, 2021
Troubling for Public Health Institution to Depart from Established Norms to… Read More
CSRXP AD BLITZ: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE NOW
Jun 1, 2021
Campaign Calls for Promises Made to the American People to Lower Prescription… Read More
CSRXP APPLAUDS PRESIDENT BIDEN’S CALL FOR BIPARTISAN SOLUTIONS TO LOWER DRUG PRICES
Apr 29, 2021
Administration and Congress Must Work Together To Pass Solutions to Hold Big… Read More
CSRXP: TIME FOR POLICYMAKERS TO DELIVER ON AMERICANS’ CALL TO LOWER OUT-OF-CONTROL DRUG PRICES
Apr 28, 2021
Holding Big Pharma Accountable Remains Top Priority for American Voters… Read More
CSRXP: HR3 REINTRODUCTION ADDS TO MOMENTUM FOR D.C. TO LOWER DRUG PRICES, HOLD BIG PHARMA ACCOUNTABLE
Apr 22, 2021
Congress and the Administration Must Act on Solutions that Have Won Bipartisan… Read More